- Boris Videlov
- Head of Pharmacovigilance Licensing
Boris Videlov, MS, PMBA, is a Head of PV Licensing at Pfizer, which he joined in 2012. In this role he is responsible for managing the PV Licensing function, leading the development and execution of long-term PV Licensing strategy, systems and processes development; PV Due Diligence; and end-to-end execution of the process governing PV relationships with business partners. He joined Pfizer from Forest Laboratories, where he was the Head PV Quality Assurance, R&D QA, responsible for conducting and hosting all PV audits, regulatory inspections, Due Diligence, and operational QA activities. Prior to that role he was the Head of Compliance & Quality Management at Forest Global Drug Safety, with responsibilities for assessment and management of compliance risk, monitoring and improvement of quality of safety information and procedures, and the development and maintenance of the PV Quality Management System. Prior to Forest Research Institute, Boris Videlov served as a Manager Contract & Project Management, Global Pharmacovigilance at Schering-Plough Research Institute. During this period he was responsible for negotiating global Pharmacovigilance Agreements in compliance with the international and local laws and regulations, developing Global Pharmacovigilance Standards, and other PV project management and operational activities. Boris Videlov began his career as a research fellow in the area of neurophysiology in 1981, and held various positions in pharmaceutical Drug Safety, Regulatory, Marketing, Consulting, and Scientific Research during his 20+ years professional experience. Boris Videlov holds a Post-MBA in Pharmaceutical Management from Fairleigh Dickinson University, MBA in Management from Long Island University, and MS in Biochemistry and Microbiology from Sofia University. Furthermore, he has published in Electricity and Magnetism in Biology and Medicine.